Loading compare…
4 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Pokarna and Sun Pharmaceutical Industries. The scheme with the highest combined exposure is Kotak Multicap Fund (Kotak MF), which holds a 0.77% stake in Pokarna and a 2.28% stake in Sun Pharmaceutical Industries, amounting to a combined conviction weight of 3.05%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Pokarna wt. | Sun wt. | Combined |
|---|---|---|---|
| Kotak Multicap FundKotak MF · Multi Cap | 0.77% | 2.28% | |
| Kotak Consumption FundKotak MF · Sectoral / Thematic | 1.74% | 1.13% | |
| Kotak Debt Hybrid FundKotak MF · Hybrid | 0.22% | 0.28% | |
| Nippon India Small Cap FundNippon India MF · Small Cap | 0.07% | 0.31% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.